34.51
price down icon49.20%   -33.42
after-market After Hours: 34.15 -0.36 -1.04%
loading
Genedx Holdings Corp stock is traded at $34.51, with a volume of 11.11M. It is down -49.20% in the last 24 hours and down -47.87% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
See More
Previous Close:
$67.93
Open:
$36.935
24h Volume:
11.11M
Relative Volume:
12.26
Market Cap:
$1.02B
Revenue:
$427.54M
Net Income/Loss:
$-21.02M
P/E Ratio:
-46.51
EPS:
-0.742
Net Cash Flow:
$14.26M
1W Performance:
-47.77%
1M Performance:
-47.87%
6M Performance:
-74.79%
1Y Performance:
-47.84%
1-Day Range:
Value
$32.84
$37.46
1-Week Range:
Value
$32.84
$69.00
52-Week Range:
Value
$32.84
$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name
Name
Genedx Holdings Corp
Name
Phone
888-729-1206
Name
Address
333 LUDLOW STREET, STAMFORD
Name
Employee
1,300
Name
Twitter
Name
Next Earnings Date
2026-05-04
Name
Latest SEC Filings
Name
WGS's Discussions on Twitter

Compare WGS vs TMO, DHR, IDXX, WAT, A

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
WGS icon
WGS
Genedx Holdings Corp
34.51 2.02B 427.54M -21.02M 14.26M -0.742
TMO icon
TMO
Thermo Fisher Scientific Inc
466.76 171.91B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
174.63 123.18B 24.78B 3.68B 5.29B 5.1743
IDXX icon
IDXX
Idexx Laboratories Inc
562.97 44.73B 4.30B 1.06B 1.04B 13.08
WAT icon
WAT
Waters Corp
342.75 29.63B 3.17B 642.63M 516.49M 10.77
A icon
A
Agilent Technologies Inc
117.53 31.70B 7.07B 1.29B 993.00M 4.5355

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-09-26 Upgrade Wells Fargo Equal Weight → Overweight
Oct-20-25 Initiated Canaccord Genuity Buy
Jul-09-25 Initiated Piper Sandler Overweight
May-15-25 Initiated Guggenheim Buy
May-09-25 Upgrade Jefferies Hold → Buy
Aug-28-24 Initiated Wells Fargo Equal Weight
Jul-10-24 Initiated Craig Hallum Buy
Jun-03-24 Resumed Jefferies Hold
View All

Genedx Holdings Corp Stock (WGS) Latest News

pulisher
08:08 AM

Cathie Wood’s ARK sells AMD stock, buys Shopify and GeneDx - Investing.com

08:08 AM
pulisher
07:38 AM

GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth - MSN

07:38 AM
pulisher
07:03 AM

WGS stock slumps after hours as firm predicts lower test volume for year - MSN

07:03 AM
pulisher
06:11 AM

WGS: GeneDX Shares Plummet Over 45%; Investors Should - GlobeNewswire

06:11 AM
pulisher
03:33 AM

Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - ChartMill

03:33 AM
pulisher
03:27 AM

GeneDx Stock Crash: WGS Plunges After Guidance Cut Raises Reimbursement Fears - TechStock²

03:27 AM
pulisher
02:58 AM

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GeneDx Holdings Corp. - ChartMill

02:58 AM
pulisher
10:27 AM

GeneDx Holdings, Duolingo, Kosmos Energy and other big stocks moving lower in Tuesday's pre-market session - MSN

10:27 AM
pulisher
09:52 AM

Genedx Holdings Corp stock hits 52-week low at 36.94 USD - Investing.com

09:52 AM
pulisher
09:02 AM

Canaccord cuts GeneDx stock price target on softer revenue outlook - Investing.com

09:02 AM
pulisher
08:47 AM

Canaccord cuts GeneDx stock price target on softer revenue outlook By Investing.com - Investing.com Canada

08:47 AM
pulisher
08:18 AM

GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2026 Earnings Call Transcript - Insider Monkey

08:18 AM
pulisher
08:10 AM

GeneDx Holdings Corp. Q1 2026 Financial Results and Forward-Looking Statements – Nasdaq: WGSWW 21 25 27 29 37 39 - Minichart

08:10 AM
pulisher
08:09 AM

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach - GlobeNewswire

08:09 AM
pulisher
08:02 AM

GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

08:02 AM
pulisher
07:13 AM

Does GeneDx’s Guidance Cut And Core Shift Reshape The Bull Case For GeneDx Holdings (WGS)? - Yahoo Finance

07:13 AM
pulisher
07:06 AM

BTIG cuts GeneDx stock price target to $90 on revenue guide cut - Investing.com UK

07:06 AM
pulisher
05:50 AM

GeneDx Holdings Corp. (WGS) reports Q1 loss, lags revenue estimates - MSN

05:50 AM
pulisher
01:11 AM

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook - BioSpace

01:11 AM
pulisher
12:04 PM

GeneDx Q1 2026 slides: volume surges 34% amid revenue headwinds By Investing.com - Investing.com Canada

12:04 PM
pulisher
May 04, 2026

Will GeneDx Holdings' (WGS) Rising Revenue and Widening Losses Recast Its Profitability Narrative? - simplywall.st

May 04, 2026
pulisher
May 04, 2026

GeneDx Q1 2026 Earnings Call Transcript - MarketBeat

May 04, 2026
pulisher
May 04, 2026

WGS Stock Slumps After Hours As Firm Predicts Lower Test Volume For Year - Stocktwits

May 04, 2026
pulisher
May 04, 2026

Genedx Earnings Call Resets Outlook Amid Strong Growth - TipRanks

May 04, 2026
pulisher
May 04, 2026

GeneDx Holdings Corp. Q1 2026 Earnings Call Summary - Yahoo Finance

May 04, 2026
pulisher
May 04, 2026

GeneDx Q1 Earnings Call Highlights - Yahoo Finance

May 04, 2026
pulisher
May 04, 2026

GeneDx Q1 2026 slides: volume surges 34% amid revenue headwinds - Investing.com

May 04, 2026
pulisher
May 04, 2026

GeneDx (WGS) Q1 2026 Earnings Transcript - AOL.com

May 04, 2026
pulisher
May 04, 2026

WGS: Q1 test volumes rose 34% but revenue missed; guidance cut, focus shifts to core growth and profitability - TradingView

May 04, 2026
pulisher
May 04, 2026

Earnings call transcript: GeneDx Q1 2026 misses earnings, stock rises slightly - Investing.com

May 04, 2026
pulisher
May 04, 2026

GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 04, 2026
pulisher
May 04, 2026

GeneDx plummets on lower 2026 guidance, Q1 misses - Seeking Alpha

May 04, 2026
pulisher
May 04, 2026

GeneDx Q1 Swings to Adjusted Loss, Revenue Rises; 2026 Revenue Guidance Lowered; Shares Fall - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

(WGS) GeneDx Now Expects Full Year 2026 Revenue Range $475M$490M, vs. FactSet Est of $550M - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

Earnings Flash (WGS) GeneDx Posts Q1 Revenue $102.3M, vs. FactSet Est of $112.5M - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

GeneDx Holdings Corp (NASDAQ:WGS) Plunges 44% After Disastrous Q1 2026 Miss - ChartMill

May 04, 2026
pulisher
May 04, 2026

GENEDX ($WGS) Releases Q1 2026 Earnings - Quiver Quantitative

May 04, 2026
pulisher
May 04, 2026

GeneDx Holdings Corp. (WGS) Stock Falls on Q1 2026 Earnings - Quiver Quantitative

May 04, 2026
pulisher
May 04, 2026

GeneDx plummets 46% as revenue guidance cut By Investing.com - Investing.com Nigeria

May 04, 2026
pulisher
May 04, 2026

(WGS) GeneDx Holdings Corp. Expects Q2 Revenue Range $110.0M$112.0M - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

GeneDx plummets 46% as revenue guidance cut - Investing.com

May 04, 2026
pulisher
May 04, 2026

Earnings Flash (WGS) GeneDx Holdings Corp. Posts Q1 Adjusted Loss $0.28 per Share - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

GeneDx : Q1 2026 Earnings Presentation PDF - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

GeneDx Holdings (WGS) grows revenue but books $63M loss on impairments - Stock Titan

May 04, 2026
pulisher
May 04, 2026

GeneDx Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 04, 2026
pulisher
May 04, 2026

GeneDx (Nasdaq: WGS) trims 2026 revenue guidance after Q1 loss widens - Stock Titan

May 04, 2026
pulisher
May 04, 2026

WGS: Q1 2026 delivered strong test volume growth but led to a downward revision in full-year revenue guidance - TradingView

May 04, 2026
pulisher
May 04, 2026

GeneDx (WGS) Q2 2025 Earnings Transcript - The Globe and Mail

May 04, 2026
pulisher
May 04, 2026

Fred Alger Management Highlights GeneDx Holdings Performance in Q1 2026 - HarianBasis.co

May 04, 2026
pulisher
May 04, 2026

Do You Believe in GeneDx Holdings Corp.’s (WGS) Durable Competitive Moat? - Insider Monkey

May 04, 2026
pulisher
May 02, 2026

Jennison Associates LLC Has $39.30 Million Position in GeneDx Holdings Corp. $WGS - MarketBeat

May 02, 2026

Genedx Holdings Corp Stock (WGS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
DGX DGX
$190.84
price down icon 0.34%
LH LH
$257.14
price up icon 1.63%
MTD MTD
$1,302.42
price up icon 3.32%
$206.77
price down icon 2.26%
IQV IQV
$176.42
price up icon 9.62%
A A
$117.53
price up icon 4.77%
Cap:     |  Volume (24h):